SCHEMBL25801266

SCHEMBL25801266

c1ccc2c(-c3ccc(-c4nc5ccccc5nc4-c4ccc(-c5cccc6ccccc56)cc4)cc3)cccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 1/20 0.49
ENPP1 P22413 1/20 0.49
L3MBTL1 Q9Y468 3/20 0.49
CA12 O43570 3/20 0.49
CA1 P00915 3/20 0.49
CA2 P00918 3/20 0.49
CA9 Q16790 3/20 0.49
KDM4E B2RXH2 3/20 0.48
LMNA P02545 3/20 0.48
GAA P10253 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
CYP1A2 P05177 1/20 0.46
ALDH1A1 P00352 3/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
AHR P35869 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23606731 0.90 ATM (0.53) ENPP3ENPP1L3MBTL1CA12CA1
SCHEMBL19543845 0.88 CYP1A2 (0.51) ENPP3ENPP1L3MBTL1CA12CA1
SCHEMBL12146605 0.87 L3MBTL1 (0.46) ENPP3ENPP1L3MBTL1CA12CA1
SCHEMBL12146632 0.86 L3MBTL1 (0.45) ENPP3ENPP1L3MBTL1CA12CA1
SCHEMBL12690621 0.86 CA12 (0.42) ENPP3ENPP1L3MBTL1CA12CA1
SCHEMBL14228010 0.86 L3MBTL1 (0.44) ENPP3ENPP1L3MBTL1KDM4ELMNA
SCHEMBL13727091 0.85 MAPK14 (0.64) L3MBTL1KDM4ELMNAGAATDP1
SCHEMBL24065771 0.85 ALDH1A1 (0.43) ENPP3ENPP1CA12CA1CA2
SCHEMBL14079789 0.84 CYP1A2 (0.54) L3MBTL1KDM4ELMNAGAATDP1
SCHEMBL6341548 0.84 ALDH1A1 (0.57) L3MBTL1KDM4ETDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 US disclosed
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-09-14 US disclosed
EP-4201930-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-06-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230292599-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 ENPP3 2217/4885ENPP1 2314/4885L3MBTL1 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.